subsequently went on to show that expression of SNAI2 is upregulated in CML patient cells as compared to normal controls and is directly upregulated by the BCR-ABL fusion oncogene that drives the majority of CML cases. Here, SNAI2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.